Iversen S A, Davidson D, Davidson C
Brighton Healthcare NHS Trust, Royal Sussex County Hospital.
Br J Clin Pharmacol. 1995 Jul;40(1):92-4. doi: 10.1111/j.1365-2125.1995.tb04542.x.
Low dose cholestyramine ('Questran A') and colestipol ('Colestid Orange') were compared in a blinded two period crossover study of 55 patients attending a hospital lipid clinic. Colestipol was rated higher on a combined acceptability/palatability score. Both treatments reduced low density lipoprotein (LDL) cholesterol to a similar extent.
在一项针对55名就诊于医院脂质门诊患者的双盲两阶段交叉研究中,对低剂量考来烯胺(“消胆胺A”)和考来替泊(“降胆宁橙剂”)进行了比较。考来替泊在可接受性/适口性综合评分上的得分更高。两种治疗方法将低密度脂蛋白(LDL)胆固醇降低的程度相似。